Analysis of symptoms and analgesic use by subjects with sickle cell trait compared with control subjects
| Variable . | SCT subjects . | Control subjects . | P* . |
|---|---|---|---|
| Nausea | 4 | 1 | — |
| Neurologic, headache | 8 | 1 | — |
| Insomnia | 4 | 0 | — |
| Fever | 1 | 0 | — |
| Chills | 1 | 0 | — |
| Myalgia | 8 | 7 | — |
| Sweats | 1 | 0 | — |
| Fatigue | 4 | 0 | — |
| Cumulative symptom score | 3.44 | 1.25 | .014 |
| Analgesia use (no. of tablets) | 13 | 6.25 | .066 |
| Variable . | SCT subjects . | Control subjects . | P* . |
|---|---|---|---|
| Nausea | 4 | 1 | — |
| Neurologic, headache | 8 | 1 | — |
| Insomnia | 4 | 0 | — |
| Fever | 1 | 0 | — |
| Chills | 1 | 0 | — |
| Myalgia | 8 | 7 | — |
| Sweats | 1 | 0 | — |
| Fatigue | 4 | 0 | — |
| Cumulative symptom score | 3.44 | 1.25 | .014 |
| Analgesia use (no. of tablets) | 13 | 6.25 | .066 |
Score given for each symptom represents the total symptom score for all 8 subjects in each group.
SCT indicates sickle cell trait.
Cumulative scores were compared by using Wilcoxon rank sum test.